Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer

by García-Carrancá Alejandro
Published 2003-01-01

Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance

by López Jacqueline, Poitevin Adela, Mendoza-Martínez Veverly, Pérez-Plasencia Carlos, García-Carrancá Alejandro
Published 2012-01-01

Prevalence of human Papillomavirus in head and neck cancer in Mexico: a case-control study

by Guido-Jiménez Miriam, Gallegos-Hernández José F, Apresa Teresa, Hernández-Hernández Dulce M, Carrera-Cáceres Samantha, García-Carrancá Alejandro
Published 2007-02-01

Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes

by Galván Silvia C, Martínez-Salazar Martha, Galván Víctor M, Méndez Rocío, Díaz-Contreras Gibran T, Alvarado-Hermida Moisés, Alcántara-Silva Rogelio, García-Carrancá Alejandro
Published 2011-11-01

Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

by López-Bayghen Esther, García-Carrancá Alejandro, Cid-Arregui Ángel, Tapia Rocio, García-Villa Enrique, Castelán-Sánchez Irma, Morales-Peza Néstor, Villanueva Rita, Gariglio Patricio
Published 2006-08-01